Skip to content

Betacel dysfunction induced by impaired pancreas anatomy and insulin sensitivity in subjects with heterozygous EXT1 or EXT2 Mutations

Betacel dysfunction induced by impaired pancreas anatomy and insulin sensitivity in subjects with heterozygous EXT1 or EXT2 Mutations - BEEM-2

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON38131
Enrollment
40
Registered
2012-01-26
Start date
2012-05-04
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Caucasian subjects (male/female), aged between 18-65 years of age with heterozygous EXT-1 or EXT-2 mutations as well as unaffected related controls matched for age and gender and subjects wiht known type 2 diabetes mellitus.

Exclusion criteria

Exclusion criteria: claustrophobia, pregnant subjects or female participant at childbearing age not using adequate anticonception, renal dysfunction during screening, exogenous insulin use.

Design outcomes

Primary

MeasureTime frame
-pancreas size (MRI)

Secondary

MeasureTime frame
- pancreas permeability (MRI)

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)